Dr. Chablani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
550 First Ave.
Nyu Langone Medical Center
New York, NY 10016Phone+1 212-263-5506- Is this information wrong?
Education & Training
- NYU Grossman School of MedicineResidency, Internal Medicine, 2016 - 2019
- Ohio State University College of MedicineClass of 2016
Certifications & Licensure
- PA State Medical License 2022 - 2024
- IL State Medical License 2019 - 2023
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Evaluation of Provider Preferences in First-Line Metastatic Renal Cell Carcinoma: Comparison Between Dual Immunotherapy vs. Immunotherapy/Tyrosine Kinase Inhibitors.Priyanka V Chablani, Theodore Karrison, Walter M Stadler> ;Clinical Genitourinary Cancer. 2022 Dec 1
- 4 citationsBRAF mutation correlates with worse local-regional control following radiation therapy in patients with stage III melanoma.Adam R. Wolfe, Priyanka Chablani, Michael Siedow, Eric D. Miller, Steve Walston, Kari Kendra, Evan Wuthrick, Terence M. Williams> ;Radiation Oncology. 2021 Apr 13
- 3 citationsDo Not Forget About the Importance of Loco-Regional Therapy in Melanoma Management.Evan Wuthrick, Priyanka Chablani> ;Seminars in Radiation Oncology. 2019 Apr 1
- Join now to see all
Press Mentions
- Practice Type Influences Oncologists’ Therapy Choice for Metastatic Renal Cell CarcinomaNovember 9th, 2021
Hospital Affiliations
- University of Chicago Medical CenterChicago, Illinois
- UPMC Presbyterian ShadysidePittsburgh, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: